Author:
Moosaie Fatemeh,Rabizadeh Soghra,Fallahzadeh Aida,Sheikhy Ali,Meysamie Alipasha,Dehghani Firouzabadi Fatemeh,Nakhjavani Manouchehr,Esteghamati Alireza
Funder
National Institute for Medical Research Development
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference54 articles.
1. Lin YC, Chang YH, Yang SY, Wu HD, Chu TS. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117(8):662–75.
2. Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2015;5(1):49–56.
3. MacIsaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014;63(Supplement 2):S39–62.
4. Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009;24(11):3265–8.
5. Skálová S. The diagnostic role of urinary N-acetyl-beta-d-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove). 2005;48(2):75–80.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献